Phase 3 Win for Modified Amino Acid in Ataxia-Telangiectasia
The modified amino acid levacetylleucine delivered clinically meaningful results in children and adults with the rare disorder ataxia-telangiectasia. Medscape Medical News
Original Source
Read the full article at Medscape →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.